CP

Caligan Partners Portfolio holdings

AUM $1.41B
1-Year Est. Return 518.95%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+518.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.41B
AUM Growth
+$321M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$38.9M
2
+$37.3M
3
+$33.2M
4
SYRE icon
Spyre Therapeutics
SYRE
+$33.1M
5
SABS icon
SAB Biotherapeutics
SABS
+$31.8M

Top Sells

1
+$25.6M
2
+$21.8M
3
+$18.4M
4
SPRB
Spruce Biosciences
SPRB
+$1.79M
5
ELDN icon
Eledon Pharmaceuticals
ELDN
+$840K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
26
CG Oncology
CGON
$4.84B
– –
0
ELDN icon
27
Eledon Pharmaceuticals
ELDN
$269M
– –
-555,978
INBX icon
28
Inhibrx
INBX
$1.36B
– –
-323,565
RAPT
29
DELISTED
RAPT Therapeutics
RAPT
– –
-644,400
SPRB
30
Spruce Biosciences
SPRB
$139M
– –
-20,514
1
2